Allena Pharmaceuticals, Inc.

Q: Sep 30 2022

Q: Jun 30 2022

Q: Mar 31 2022

FY: Dec 31 2021

FY: Dec 31 2021

Q: Sep 30 2021

FY: Dec 31 2020

Q: Mar 31 2021

Q: Jun 30 2021

Q: Jun 30 2021

Q: Mar 31 2021

FY: Dec 31 2020

Q: Sep 30 2020

Q: Jun 30 2020

Q: Mar 31 2020

FY: Dec 31 2019

FY: Dec 31 2019

Q: Sep 30 2019

Q: Jun 30 2019

Q: Mar 31 2019

3.01

1.02,1.03,3.01,5.02

3.01

8.01,9.01

5.07

1.01,3.02,3.03,5.03,8.01,9.01

1.01,9.01

2.02,8.01,9.01

8.01,9.01

1.02

1.02

1.01,3.02,3.03,5.03,8.01,9.01

Other Events

3.01,8.01

5.02,9.01

2.02,8.01,9.01

1.01,1.02,8.01,9.01

2.02,9.01

8.01,9.01

3.01

Notification of removal from listing and/or registration on a national securities exchange

Prospectus Supplement for Primary Offering

Registration (IPO) statement under Securities Act of 1933

06b

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Notice of Effectiveness

Prospectus Supplement for Primary Offering

Free Writing Prospectus

Free Writing Prospectus

Prospectus Supplement for Primary Offering

Free Writing Prospectus

Registration statement under Securities Act of 1933

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

none

Point72 Asset Management, L.P.

Katz Richard D

BRENNER LOUIS MD

none

none

BRENNER LOUIS MD

Alexander Robert

SANTINI GINO

Margolin Alexey L

Diaz Allene M.

Miller Ann Calby

BRENNER LOUIS MD

Fitzpatrick Mark J.

Fitzpatrick Mark J.

BRENNER LOUIS MD

Deer VII & Co. Ltd.

FMR LLC

Katz Richard D

Katz Richard D

No description available

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

No description available

No description available

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Draft registration statement (confidential submission) (amendment)

No description available

Draft registration statement (confidential submission) (amendment)

Letter from the SEC

Draft registration statement (confidential submission)